Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): Interim Results for the First 170 Subjects with Blepharospasm.

Fernandez HH, Jankovic J, Holds JB, Lin D, Burns J, Verma A, Sethi K, Pappert EJ.

Tremor Other Hyperkinet Mov (N Y). 2014 Jul 16;4:238. doi: 10.7916/D8MK6B1B.

IPX066 , a mixed immediate/sustained-release levodopa preparation for Parkinson's disease.

Ondo W.

Expert Opin Pharmacother. 2014 Oct;15(14):2081-5. doi: 10.1517/14656566.2014.950224. Review.

Clinical efficacy and sEMG analysis of a new traditional Chinese medicine therapy in the treatment of spasticity following apoplectic hemiparalysis.

Zhu W, Zheng G, Gu Y, Chen X, Jin Y, Zhang G, Huang J, Shen J.

Acta Neurol Belg. 2014 Jun;114(2):125-9. doi: 10.1007/s13760-014-0279-x.

Ataxia and Purkinje cell degeneration in mice lacking the CAMTA1 transcription factor.

Long C, Grueter CE, Song K, Qin S, Qi X, Kong YM, Shelton JM, Richardson JA, Zhang CL, Bassel-Duby R, Olson EN.

Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11521-6. doi: 10.1073/pnas.1411251111.

CHRNB3 c.-57A>G functional promoter change affects Parkinson's disease and smoking.

Bar-Shira A, Gana-Weisz M, Gan-Or Z, Giladi E, Giladi N, Orr-Urtreger A.

Neurobiol Aging. 2014 Sep;35(9):2179.e1-6. doi: 10.1016/j.neurobiolaging.2014.03.014.

Formulations of hormone therapy and risk of Parkinson's disease.

Lundin JI, Ton TG, LaCroix AZ, Longstreth WT, Franklin GM, Swanson PD, Smith-Weller T, Racette BA, Checkoway H.

Mov Disord. 2014 Nov;29(13):1631-6. doi: 10.1002/mds.26037.

Psychometric properties of 3 functional mobility tests for people with Parkinson disease.

Verheyden G, Kampshoff CS, Burnett ME, Cashell J, Martinelli L, Nicholas A, Stack EL, Ashburn A.

Phys Ther. 2014 Feb;94(2):230-9. doi: 10.2522/ptj.20130141.

Astrovirus as a possible cause of congenital tremor type AII in piglets?

Blomström AL, Ley C, Jacobson M.

Acta Vet Scand. 2014 Dec 16;56:82. doi: 10.1186/s13028-014-0082-y.

Comparing cerebral perfusion in Alzheimer's disease and Parkinson's disease dementia: an ASL-MRI study.

Le Heron CJ, Wright SL, Melzer TR, Myall DJ, MacAskill MR, Livingston L, Keenan RJ, Watts R, Dalrymple-Alford JC, Anderson TJ.

J Cereb Blood Flow Metab. 2014 Jun;34(6):964-70. doi: 10.1038/jcbfm.2014.40.

Long-term outcome of deep brain stimulation in generalised dystonia: a series of 60 cases.

FitzGerald JJ, Rosendal F, de Pennington N, Joint C, Forrow B, Fletcher C, Green AL, Aziz TZ.

J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1371-6. doi: 10.1136/jnnp-2013-306833.

[Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].

Zheng L, Wang H, Ba YY, Liu HL, Wang M, Guo WW, Wu X, Yang H.

Zhongguo Zhong Yao Za Zhi. 2014 May;39(9):1660-5. Chinese.

Beyond the glutamine expansion: influence of posttranslational modifications of ataxin-1 in the pathogenesis of spinocerebellar ataxia type 1.

Ju H, Kokubu H, Lim J.

Mol Neurobiol. 2014 Dec;50(3):866-74. doi: 10.1007/s12035-014-8703-z. Review.

Motivational modulation of bradykinesia in Parkinson's disease off and on dopaminergic medication.

Kojovic M, Mir P, Trender-Gerhard I, Schneider SA, Pareés I, Edwards MJ, Bhatia KP, Jahanshahi M.

J Neurol. 2014 Jun;261(6):1080-9. doi: 10.1007/s00415-014-7315-x.

Effectiveness of Anma massage therapy in alleviating physical symptoms in outpatients with Parkinson's disease: a before-after study.

Donoyama N, Suoh S, Ohkoshi N.

Complement Ther Clin Pract. 2014 Nov;20(4):251-61. doi: 10.1016/j.ctcp.2014.07.010.

Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin.

Rhodes SL, Buchanan DD, Ahmed I, Taylor KD, Loriot MA, Sinsheimer JS, Bronstein JM, Elbaz A, Mellick GD, Rotter JI, Ritz B.

Neurobiol Dis. 2014 Feb;62:172-8. doi: 10.1016/j.nbd.2013.09.019.